CION Ameerpet
Staging Explained · Reviewed by CION Oncologists · NABH Accredited
Stage 3 Endometrial Cancer — Beyond the Uterus, Within the Pelvis
Stage 3 means the cancer has spread past the uterus but has not reached distant organs. It is still within the pelvis and abdomen — the ovaries, the outer surface of the uterus, the vagina, or the lymph nodes that drain the area. It is still treated with the aim of curing it, and that is not a form of words: combined treatment at this stage cures a meaningful proportion of women. What this page also has to say plainly is that stage 3 covers an unusually wide range, from a few microscopic cells in one node to visibly involved nodes high in the abdomen, and those are not the same situation.
- Spread beyond the uterus — to the ovaries, the uterine surface, the vagina, or the lymph nodes
- Not to distant organs — no lung, liver or bone involvement — that would be stage 4
- Still treated to cure — surgery plus chemotherapy and radiation is the usual combination
- A wide range within one number — microscopic node involvement is not the same as bulky disease
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
What Stage 3 Actually Means
Stage 3 is defined by where the cancer has reached, and FIGO divides it according to the route it took. Understanding which subdivision applies to you matters more than the number itself.
- To the outer surface of the uterus, or to the ovaries and tubes. The tumour has grown through the full thickness of the uterine wall to its outer covering, or has reached the ovaries or fallopian tubes. Sometimes found only when the specimen is examined.
- To the vagina, or to the tissue beside the uterus. Direct extension into the vagina, or into the parametrium — the supporting tissue on either side of the uterus.
- To the pelvic lymph nodes. Cancer cells have reached the nodes within the pelvis. This is the commonest route of spread for endometrial cancer, and is the reason node assessment is part of the operation. See lymph node involvement.
- To the para-aortic lymph nodes. Nodes higher in the abdomen, alongside the main artery. Further along the same drainage route, and treated as a more advanced position within stage 3.
What stage 3 is not: spread to the bladder or bowel lining, or to organs outside the abdomen and pelvis such as the lungs, liver or bones. Those define stage 4. For how the whole system fits together, see FIGO staging explained.
Did You Know? Stage 3 is the stage where the number on the report tells you least. It stretches from a single microscopic deposit found in one sentinel lymph node — disease so small it would have been invisible without the pathologist looking for it — to bulky nodes high in the abdomen visible on a scan. Both are labelled stage 3, and their outlooks are not comparable. This is one of the reasons modern staging has moved towards incorporating molecular classification: a p53-abnormal tumour and a POLE-mutated tumour at the same anatomical stage behave quite differently, and treating them identically because they share a number is no longer regarded as good practice. Sources: FIGO staging for cancer of the endometrium; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
The Range Inside One Number
Two women can both be told they have stage 3 endometrial cancer and be in genuinely different positions. This is not a technicality — it changes the treatment and it changes the conversation about outlook.
| Situation | What it means in practice |
|---|---|
| Microscopic deposit in one sentinel node | Found only because the node was removed and examined in detail. Disease burden is tiny. Treatment is intensified, but this is at the favourable end of stage 3 and the aim is firmly cure. |
| Ovarian involvement in a younger woman | Worth flagging specifically: in younger women, simultaneous low-grade tumours of the uterus and ovary are sometimes two separate early cancers rather than one that has spread. That distinction changes the outlook substantially and is made on pathology. |
| Serosal involvement | The tumour has reached the outer covering of the uterus, which opens a route into the abdominal cavity. Systemic treatment features more prominently for this reason. |
| Vaginal or parametrial extension | Direct local spread. Radiation to the pelvis has a central role here, both to treat what is there and to reduce the risk of local recurrence. |
| Multiple or bulky pelvic nodes | A greater disease burden with a higher risk of cells having travelled further. Both chemotherapy and radiation are usually part of the plan. |
| Para-aortic node involvement | Disease has tracked up the drainage route into the abdomen. Radiation fields are extended accordingly, and this sits at the more advanced end of stage 3. |
The question to ask: not “what is the survival for stage 3”, which averages across all of the above and will not describe you, but “which part of stage 3 am I in, and what does that mean for my treatment”. Any oncologist treating you can answer the second question. Nobody can honestly answer the first in a way that applies to an individual.
Been Told It Is Stage 3?
This is the stage where a tumour board genuinely earns its place. Bring everything you have and we will review it as a team.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Stage 3 Is Still Treated With the Intention of Curing It
Combined treatment cures a meaningful proportion of women at this stage. It needs to be planned as one plan, not three separate ones.
The combined approach
What Treatment at Stage 3 Involves
Stage 3 is where all three arms of oncology come together, and the order they come in is itself a decision. Here is what each part does and why it is there.
Surgery: removing what can be removed, and establishing the truth
The operation removes the uterus, cervix, tubes and ovaries, and assesses the lymph nodes. At stage 3 it does two jobs. It removes disease, and it establishes exactly what is present and where — which is what the rest of the plan is built on. Where disease is visible beyond the uterus, removing as much as can be safely removed is generally associated with better outcomes. In some women, particularly where imaging shows extensive disease at the outset, the order is reversed and drug treatment comes first to shrink things before surgery is attempted.
Chemotherapy: treating what cannot be seen
Once cancer has reached the lymph nodes or the surface of the uterus, there is a real chance that cells have travelled further than anything visible. Chemotherapy is systemic — it circulates — so it addresses that risk in a way that surgery and radiation, which treat defined areas, cannot. It is a standard part of stage 3 treatment. In line with our editorial policy on these pages we describe treatment by class rather than naming individual medicines; the specific regimen, number of cycles and schedule are decisions for the medical oncologist treating you. See chemotherapy for endometrial cancer.
Radiation: holding the pelvis
Radiation treats the region where the disease was, reducing the risk that it returns there. At stage 3 the field usually covers the pelvis, extended to include the para-aortic region where nodes there were involved, often with a brachytherapy boost to the vaginal vault. Modern conformal and intensity-modulated planning shapes the dose around bowel, bladder and bone marrow, which matters a great deal when radiation is being combined with chemotherapy. See pelvic radiation.
The sequencing question
Whether chemotherapy comes first, radiation comes first, or the two are interleaved is one of the genuinely debated areas in endometrial cancer, and reasonable teams differ. What matters more than the specific answer is that the decision is made by the whole team at once rather than by each specialty in turn: a plan where the surgeon, the medical oncologist and the radiation oncologist each decide their own part sequentially tends to produce a worse combined result than one designed as a whole. This is the concrete reason tumour boards exist.
Immunotherapy, where the tumour biology supports it
Endometrial cancers with mismatch repair deficiency respond notably well to checkpoint-blocking immunotherapy, and this has changed the outlook for a subset of women with advanced disease. Whether it has a role at stage 3 rather than in recurrent or metastatic disease depends on the specifics of the case and on evolving evidence. Testing every tumour for mismatch repair status is what makes the question answerable, which is one of several reasons it is done routinely. See immunotherapy for endometrial cancer.
Supportive care, planned from the start rather than added later
Combined chemotherapy and radiation to the pelvis is demanding, and the difference between completing a plan and abandoning it halfway is often supportive care. Nutrition, management of bowel and bladder effects, attention to lymphoedema risk after node surgery, and psychological support all belong in the plan from the beginning. This is not softness around the edges of the treatment; women who are supported through it are the ones who finish it. See leg lymphoedema.
Want a Tumour Board Opinion on a Stage 3 Plan?
At this stage the sequence of surgery, chemotherapy and radiation should be decided by the whole team at once. Bring what you have. The opinion is free.
Talking Honestly About the Outlook
Women arrive at this page having searched for a number, and the honest response is that a single number for stage 3 would misinform more than it informs. Stage 3 spans a microscopic node deposit and bulky abdominal nodal disease; averaging them produces a figure that describes neither.
What can be said clearly:
- Cure is a realistic aim at this stage. That is why treatment is given in combination and why it is demanding. It is not palliative treatment, and it should not be described to you as though it were.
- The subdivision matters more than the number. A single microscopic sentinel node deposit sits at a very different point from involved para-aortic nodes. Ask which applies to you.
- Biology matters as much as anatomy now. Histological type and molecular group shape the outlook alongside the extent of spread. A p53-abnormal tumour and a POLE-mutated tumour at the same stage are in different positions.
- We do not publish a CION endometrial survival figure. Indian registry data for this cancer specifically is limited, and we would rather say so than print a number we cannot stand behind. See survival by stage.
For what monitoring looks like afterwards and what recurrence would involve, see endometrial cancer recurrence and the follow-up schedule.
Why Stage 3 Needs Everything in One Place
Three treatments planned by three teams in three hospitals is how stage 3 care goes wrong. It should be one plan.
Tumour board for every diagnosis
One place for the whole pathway
Image-guided pelvic radiation
MMR / MSI testing as standard
Named MCh surgical oncologists
Psycho-oncology and nutrition on the team
Take The Next Step
Stage 3 Is Demanding Treatment With a Real Goal
It is worth having it planned properly, by people who treat this often. Let us look at your case together.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Stage 3 Endometrial Cancer — Frequently Asked Questions
What does stage 3 endometrial cancer mean?
It means the cancer has spread beyond the uterus but remains within the pelvis and abdomen, without reaching distant organs. FIGO divides stage 3 by where the spread is: to the outer surface of the uterus or to the ovaries and tubes; to the vagina or the supporting tissue beside the uterus; to the pelvic lymph nodes; or to the para-aortic nodes higher in the abdomen. Spread to the lining of the bladder or bowel, or to organs such as the lungs, liver or bones, would be stage 4. Which subdivision applies to you matters considerably more than the number, because the range within stage 3 is very wide.
Is stage 3 endometrial cancer curable?
It is treated with the intention of curing it, and a meaningful proportion of women at this stage are cured. That is why the treatment is combined and demanding rather than palliative — surgery to remove disease and establish exactly what is present, chemotherapy to address cells that may have travelled beyond anything visible, and radiation to hold the region where the disease was. The honest qualification is that stage 3 covers a wide range, from a microscopic deposit in a single sentinel lymph node to bulky nodes in the upper abdomen, and those situations do not carry the same outlook. If you are given a single survival figure for "stage 3", it is an average across all of them.
Will I need both chemotherapy and radiation?
At stage 3 the usual approach combines them, because they do different jobs. Radiation treats a defined region — typically the pelvis, extended to the para-aortic area where nodes there were involved — and reduces the risk of the cancer returning in that region. Chemotherapy circulates through the body and addresses the risk that cells have travelled further than anything that can be seen or targeted. Once cancer has reached lymph nodes or the outer surface of the uterus, that risk is real, which is why systemic treatment enters the plan. The sequence — whether chemotherapy comes first, radiation first, or the two are interleaved — is genuinely debated and should be decided by the whole team together.
Why is stage 3 sometimes only found after surgery?
Because some of what defines stage 3 cannot be seen before the operation. MRI and PET-CT can show enlarged lymph nodes and obvious spread, but they cannot detect small deposits inside nodes of normal size, and they cannot reliably see microscopic involvement of the ovaries or the outer surface of the uterus. Those findings come from the pathologist examining the removed tissue. It is genuinely common for a woman to go into surgery expecting stage 1 and be told afterwards that a sentinel node contained tumour cells. It is unsettling, but it is also the system working — the node was removed and examined precisely so the plan could be built on what is actually there.
Does stage 3 mean the cancer will come back?
No. Stage 3 means a higher risk of recurrence than earlier stages, and that risk is exactly what the combined treatment is designed to reduce. Many women treated at this stage do not have a recurrence. The risk varies substantially within stage 3 — a single microscopic node deposit and extensive para-aortic involvement are not comparable — and it is also shaped by histological type and molecular group, not only by how far the cancer travelled. Follow-up after treatment is closer in the first years for this reason, and it focuses on the vaginal vault and the pelvis, where recurrence most often appears first.
Medical disclaimer: This page explains FIGO stage 3 endometrial cancer in general terms and is reviewed by a CION oncologist, following the FIGO staging system and current NCCN and ESGO–ESTRO–ESP guidance. It describes treatment by drug class rather than naming individual medicines, because regimen and schedule are individual clinical decisions. It is not advice about your own case and does not predict an outcome for any particular woman. Indian registry data for endometrial cancer specifically is limited, and we do not publish a CION endometrial survival figure for that reason.